Nuclear receptor subfamily 2 group E member 3 (NR2E3) (NR2E3)

Nuclear receptor subfamily 2 group E member 3 (NR2E3), also known as photoreceptor-specific nuclear receptor (PNR), is an orphan nuclear receptor that plays a pivotal role in the development and maintenance of the vertebrate retina (UniProt Consortium, 2024). It functions as a transcription factor that is essential for determining photoreceptor cell fate, specifically by promoting the differentiation of rod photoreceptors and actively suppressing the expression of cone-specific genes (NCBI Gene, 2024). NR2E3 operates within a complex transcriptional network, interacting with other factors such as NRL and CRX to regulate retinal homeostasis. Mutations in the NR2E3 gene are linked to several hereditary retinal diseases, most notably Enhanced S-cone syndrome (ESCS), where patients exhibit an overabundance of S-cones and a lack of functional rods, leading to night blindness and macular degeneration (PubMed, 2023). Because of its tissue-specific expression and central role in retinal disease, NR2E3 is a significant target for gene therapy and small-molecule drug discovery aimed at treating inherited blindness. Current therapeutic strategies focus on restoring NR2E3 function or modulating its activity to preserve photoreceptor health and visual function (ClinicalTrials.gov, 2024).

Other names

Photoreceptor-specific nuclear receptorPNREnhanced S-cone syndrome proteinESCSRetinal nuclear receptorRNRRP37

NR2E3 acts as a transcriptional repressor of cone-specific genes and an activator of rod-specific genes by binding to specific DNA response elements, often in coordination with other factors like NRL and CRX (UniProt Consortium, 2024).